NutrInvest - Institut Pasteur de Lille
Lille, Nord, 59019, France
NCT Number: NCT02353403
The study aims to evaluate the glycaemic and insulinaemic response of short-chain fructo-oligosaccharides (scFOS) used to replace sugars (e.g. dextrose) in foods.
Looking for future studies?
Notify Me18 year–50 year
All sexes
Interventional
Not applicable
Lille, Nord, 59019, France
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
A 210g chocolate dairy dessert made with 35g of dextrose.
A 210g chocolate dairy dessert made with 24g of dextrose and 11.2g of FOS.
Time frame: 2 hours and 5 minutes
Blood glucose kinetics with 7 points. Analysis of the Area under the curve of glucose.
Time frame: 2 hours and 5 minutes
Blood insulin kinetics with 7 points. Analysis of the Area under the curve of insulin.
Time frame: One-time data (the highest one) within the 2hrs 5mins kinetics.
Peak of blood glucose during kinetics.
Time frame: One-time data (the highest one) within the 2hrs 5mins kinetics.
Peak of blood insulin during kinetics.
Time frame: One time within the 2hrs 5mins kinetics.
Time frame: One time within the 2hrs 5mins kinetics.
Institut Pasteur de Lille
Other
Postprandial Glycaemic and Insulinaemic Responses After Consumption of Dairy Desserts Containing Fructo-oligosaccharides in Adults.
Acronym: GLYCOFOS-cream
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07054476
Diabetes Mellitus, Endocrine System Diseases
Ankara, Altındağ, Turkey (Türkiye)
View Trial DetailsNCT02352857
Glycaemia
Lille, Nord, France
View Trial DetailsNCT01870570
Glycaemia, Insulinemia
Sydney, Australia
View Trial DetailsNCT05317429
Glycaemia
Norwich, Norfolk, United Kingdom
View Trial Details